Compounds > bucladesine

bucladesine and MS (Multiple Sclerosis)

bucladesine has been researched along with MS (Multiple Sclerosis) in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baer, A; Franklin, RJ; González, GA; Hofer, MP; Huang, JK; Kotter, MR; Lubec, G; Myrta, S; Rossner, MJ; Rundle, J; Syed, YA; Trotter, MW; Zhao, C1
Giorelli, M; Livrea, P; Trojano, M1
Dinter, H; Martin, R; McFarland, HF; Muraro, PA; Pette, DF; Pette, M1
Comabella, M; Imitola, J; Khoury, SJ; Makhlouf, K; Weiner, HL1
Barna, BP; Estes, ML; Jacobs, BS; McMahon, JT; Ransohoff, RM1

Other Studies

5 other study(ies) available for bucladesine and MS (Multiple Sclerosis)

ArticleYear
Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.
    EMBO molecular medicine, 2013, Volume: 5, Issue:12

    Topics: Animals; Bucladesine; Cell Differentiation; Cells, Cultured; Central Nervous System; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Immunity, Innate; Mitogen-Activated Protein Kinases; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Transcriptome

2013
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients.
    Journal of neuroimmunology, 2004, Volume: 155, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adult; beta-Adrenergic Receptor Kinases; Bucladesine; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Female; Humans; Interferon-gamma; Isoproterenol; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Neuroimmunomodulation; Receptors, Adrenergic, beta-2; Signal Transduction; Up-Regulation

2004
Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones.
    Journal of neuroimmunology, 1999, Aug-03, Volume: 98, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Antibodies; Autoantigens; Bucladesine; Cell Division; Clone Cells; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Interleukin-10; Interleukin-2; Lymphotoxin-alpha; Multiple Sclerosis; Myelin Proteins; Myelin Sheath; Oligonucleotide Probes; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Interleukin-2; RNA, Messenger; Rolipram; T-Lymphocytes; Tumor Necrosis Factor-alpha

1999
Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.
    Journal of neuroimmunology, 2001, Jul-02, Volume: 117, Issue:1-2

    Topics: Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; B7-1 Antigen; Bucladesine; CD40 Antigens; Dendritic Cells; Female; Humans; Interleukin-12; Lipopolysaccharides; Male; Middle Aged; Monocytes; Multiple Sclerosis

2001
Characterization of adult human astrocytes derived from explant culture.
    Journal of neuroscience research, 1990, Volume: 27, Issue:4

    Topics: Adult; Astrocytes; Bromodeoxyuridine; Bucladesine; Cell Line; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Microscopy, Electron; Multiple Sclerosis

1990